Form 4 for CDNA CareDx, Inc.
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-02 · accession 0001217234-22-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-04 | 2022-02-02 | CDNA | Johnson Alexander L | Chief Business Off | A - Grant | $0.00 | +19.9K | 59.4K | +50% | $0 |
| D | 2022-02-04 | 2022-02-02 | CDNA | Johnson Alexander L | Chief Business Off | A - Grant | $0.00 | +29.9K | 29.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-02 | A | A | 19,900 | $0.00 | 59,413 | D | — | — | (F1) The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 2, 2023 and 1/4th of which shall vest on each anniversary thereafter. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | A | A | 29,900 | $0.00 | 29,900 | D | $41.32 · — to 2032-02-02 | 29,900 Common Stock | (F2) 1/4th of the shares subject to the option shall vest on February 2, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter. |